최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Nutrition research, v.36 no.9, 2016년, pp.914 - 924
Jang, S.A. , Lee, S. , Sohn, E.H. , Yang, J. , Park, D.W. , Jeong, Y.J. , Kim, I. , Kwon, J.E. , Song, H.S. , Cho, Y.M. , Meng, X. , Koo, H.J. , Kang, S.C.
Excessive consumption of fat and fructose augments the pathological progression of nonalcoholic fatty liver disease through hepatic fibrosis, inflammation, and hepatic de novo lipogenesis. We hypothesized that supplementation with Cynanchum wilfordii extract (CWE) decreases fat accumulation in the l...
Rev Recent Clin Trials Almeda-Valdes 9 148 2014 10.2174/1574887109666141216103908 Common features of the metabolic syndrome and nonalcoholic fatty liver disease
Hepatology Browning 40 1387 2004 10.1002/hep.20466 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
Gastroenterol Res Pract Song 2013 2013 10.1155/2013/342648 Time course of the development of nonalcoholic fatty liver disease in the Otsuka Long-Evans Tokushima fatty rat
J Lipid Res Subramanian 52 1626 2011 10.1194/jlr.M016246 Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
Hepatology Yu 43 826 2006 10.1002/hep.21108 COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator
Gastroenterology Day 114 842 1998 10.1016/S0016-5085(98)70599-2 Steatohepatitis: a tale of two “hits”?
Cochrane Database Syst Rev Eslami 12 CD008623 2013 Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Metabolism Aguilar-Olivos 2015 The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
J Ethnopharmacol Shan 107 389 2006 10.1016/j.jep.2006.03.022 Gastroprotective effect of a traditional Chinese herbal drug “Baishouwu” on experimental gastric lesions in rats
Biol Pharm Bull Yang 37 1390 2014 10.1248/bpb.b13-00939 Cynandione A from Cynanchum wilfordii attenuates the production of inflammatory mediators in LPS-induced BV-2 microglial cells via NF-κB inactivation
Hypertension Ackerman 45 1012 2005 10.1161/01.HYP.0000164570.20420.67 Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction
J Hepatol Ouyang 48 993 2008 10.1016/j.jhep.2008.02.011 Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Hepatology Farrell 43 S99 2006 10.1002/hep.20973 Nonalcoholic fatty liver disease: from steatosis to cirrhosis
Mol Med Rep Chen 4 811 2011 Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats
Hepatol Res Cheng 23 185 2002 10.1016/S1386-6346(01)00177-2 Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis
Clin Cancer Res Kondo 5 4005 1999 Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma
Prostaglandins Leukot Essent Fatty Acids Hu 69 329 2003 10.1016/j.plefa.2003.07.001 Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases
J Clin Exp Hepatol Sharma 5 147 2015 10.1016/j.jceh.2015.02.002 The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis
Int J Clin Exp Med Zeng 7 1624 2014 Signal transductions and nonalcoholic fatty liver: a mini-review
World J Gastroenterol Basaranoglu 19 1166 2013 10.3748/wjg.v19.i8.1166 Fructose as a key player in the development of fatty liver disease
Int J Mol Med Koo 35 915 2015 10.3892/ijmm.2015.2112 An ethanol root extract of Cynanchum wilfordii containing acetophenones suppresses the expression of VCAM-1 and ICAM-1 in TNF-α-stimulated human aortic smooth muscle cells through the NF-κB pathway
Exp Biol Med (Maywood) Meng 241 396 2016 10.1177/1535370215614657 Anti-inflammatory effects of Saururus chinensis aerial parts in murine macrophages via induction of heme oxygenase-1
Behav Res Methods Faul 39 175 2007 10.3758/BF03193146 G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Hepatol Int de Moraes 5 965 2011 10.1007/s12072-011-9275-x Protective effects of green tea against hepatic injury induced by high-cholesterol diet in rats: histopathological analysis, oxidative DNA damage and COX-2 expression
Am J Physiol Lung Cell Mol Physiol Singer 285 L1087 2003 10.1152/ajplung.00409.2002 p38 MAPK and NF-kappaB mediate COX-2 expression in human airway myocytes
Prostaglandins Other Lipid Mediat Tanabe 68-69 95 2002 10.1016/S0090-6980(02)00024-2 Cyclooxygenase isozymes and their gene structures and expression
ISRN Endocrinol Matsuda 2013 472432 2013 10.1155/2013/472432 Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic fatty liver disease
J Dig Dis Demir 16 10 541 2015 10.1111/1751-2980.12291 Nonalcoholic fatty liver disease: current status and future directions
Environ Health Prev Med Kitamori 17 173 2012 10.1007/s12199-011-0235-9 Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr
World J Gastroenterol Milic 20 9330 2014 Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations
World J Hepatol Zambo 5 550 2013 10.4254/wjh.v5.i10.550 Lipotoxicity in the liver
Exp Gerontol Wang 48 705 2013 10.1016/j.exger.2013.05.059 Prevalence and associated metabolic factors of fatty liver disease in the elderly
Ann N Y Acad Sci Giannitrapani 1155 293 2009 10.1111/j.1749-6632.2009.03698.x Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study
Obesity (Silver Spring) Hsieh 17 1150 2009 10.1038/oby.2008.674 COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver
Science Cannon 336 1386 2012 10.1126/science.1224398 Physiology. COX-2 inhibitors and cardiovascular risk
J Hepatol Leclercq 41 926 2004 10.1016/j.jhep.2004.08.010 . Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice
Hepatology Matsuzawa 46 1392 2007 10.1002/hep.21874 Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.